A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2004
12/23/2004	WO2004111051A1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments
12/23/2004	WO2004111048A1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them
12/23/2004	WO2004111038A1 5,6-bis (4-chlorophenyl)-n-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide
12/23/2004	WO2004111037A1 Cyclic tertiary amine compound
12/23/2004	WO2004111033A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
12/23/2004	WO2004111032A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
12/23/2004	WO2004111031A1 Pyridinyl carbamates as hormone-sensitive lipase inhibitors
12/23/2004	WO2004111028A1 Cyclic onium compounds and glucosidase inhibitors
12/23/2004	WO2004111025A1 Para-substituted phenyl carbamates as inhibitors of hormone sensitive lipase
12/23/2004	WO2004111020A1 Aniline derivatives
12/23/2004	WO2004111019A2 Protective groups cleavable by serumal albumins
12/23/2004	WO2004111008A2 Use of a compound of formula i for making a pharmaceutical composition
12/23/2004	WO2004111007A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
12/23/2004	WO2004111006A1 Para-subtituted phenyl carbamates as inhibitors of hormone sensitive lipase
12/23/2004	WO2004111004A1 Substituted piperazine carbamates for use as inhibitors of hormone sensitive lipase
12/23/2004	WO2004111002A1 2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide
12/23/2004	WO2004111001A1 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl) piperidine as glucosylceramide synthase (gcs)
12/23/2004	WO2004110988A1 Protease inhibitors
12/23/2004	WO2004110985A1 Pharmaceutically useful salts of carboxylic acid derivates
12/23/2004	WO2004110984A1 Pharmaceutically useful salts of carboxylic acid derivates
12/23/2004	WO2004110489A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE
12/23/2004	WO2004110472A2 Fusion proteins
12/23/2004	WO2004110467A1 Natural extract with hypoglycaemic activity and method of obtaining same
12/23/2004	WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
12/23/2004	WO2004110453A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	WO2004110422A1 Extended-release tablets of metformin
12/23/2004	WO2004110419A1 Agonist agents and medicinal compositions
12/23/2004	WO2004110409A1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation
12/23/2004	WO2004110379A2 A1 adenosine receptor antagonists
12/23/2004	WO2004089917A3 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome
12/23/2004	WO2004089471A3 NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/23/2004	WO2004089470A3 New amide derivatives and pharmaceutical use thereof
12/23/2004	WO2004089380A3 Pharmaceutical use of fused 1,2,4-triazoles
12/23/2004	WO2004085409A3 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
12/23/2004	WO2004072025A3 Substituted n-arylheterocycles, method for production and use thereof as medicaments
12/23/2004	WO2004049095A3 Betaine and salicylic acid compositions
12/23/2004	WO2003095438A9 Substituted phenylacetamides and their use as glucokinase activators
12/23/2004	US20040259938 Novel dipheylenthylene compounds
12/23/2004	US20040259932 Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure
12/23/2004	US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/23/2004	US20040259925 Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
12/23/2004	US20040259918 treatment of diabetes mellitus with compounds of given formula such as sulfonamides and an antidiabetic agent such as sulfonylureas, biguanides, glitazones, alpha-glucosidase inhibitors, glucagon antagonists
12/23/2004	US20040259917 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
12/23/2004	US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence
12/23/2004	US20040259910 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
12/23/2004	US20040259903 Pyrido [2,1-a] isoquinoline derivatives
12/23/2004	US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes
12/23/2004	US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example
12/23/2004	US20040259887 Cannabinoid receptor ligands and uses thereof
12/23/2004	US20040259886 Compositions and methods for treating osteoporosis and lowering cholesterol
12/23/2004	US20040259883 Thiazolidine derivative and medicinal use thereof
12/23/2004	US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents
12/23/2004	US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists
12/23/2004	US20040259865 Laxative; adenosine receptor antagonist
12/23/2004	US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors
12/23/2004	US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof
12/23/2004	US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity
12/23/2004	US20040259819 Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
12/23/2004	US20040259780 Method for treating diabetes and obesity
12/23/2004	US20040259778 Utilization of histamine receptor h3 gene participating in body weight or food intake control
12/23/2004	US20040258829 polysaccharides isolated from cereal grains, having narrow molecular weigth distribution, low viscosity and high stability in water; enzymatic hydrolysis; used in foods, beverages and anticholesterol agents
12/23/2004	US20040258826 Matrix-forming composition containing pectin
12/23/2004	US20040258813 Dehydrating; steaming; drying; freezing; pulverization
12/23/2004	US20040258777 Aqueous topical solutions stimulate endothelial growth factors and microcirculation; solvent extraction with volatile non-aqueous solvents; obestity; reduction of cellulite and localized dermal adipose deposits
12/23/2004	US20040258776 Composition comprising aleurone, method of administering the same, and method of manufacturing the same
12/23/2004	US20040258772 Methods of treating angiogenesis, tumor growth, and metastasis
12/23/2004	US20040258758 Stabilizer adsorped on particle surface; adhere to gut increasing time for absorption, and effectiveness; low dosage; antiepileptic, anxiolytic and antidepressant agents; post traumatic stress syndrome bipolar and psychological disorders; schizophrenia
12/23/2004	US20040258730 Sustained relase film comprises (11Apha ,13E,15 alpha )-9-oxo-11,15-dihydroxy-16-(3-methoxymethylphenyl)-17,18,19,20-tetranor-5-thiaprost-13-enoic acid methyl ester to treat bone mass disorders; osteoporosis, metastatic bone, hypercalcemia, and Paget's disease
12/23/2004	US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies
12/23/2004	DE10308355A1 Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Aryl-cycloalkyl substituted alkane acid derivatives, processes for their preparation and their use as medicaments
12/23/2004	DE10308354A1 Cycloalkylderivate mit biosteren Carbonsäure-Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Cycloalkyl biosteren with carboxylic acid groups, method for their preparation and their use as medicaments
12/23/2004	CA2529729A1 New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
12/23/2004	CA2529068A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	CA2528932A1 Pharmaceutically useful salts of carboxylic acid derivates
12/23/2004	CA2528929A1 Cyclic tertiary amine compound
12/23/2004	CA2528883A1 Pharmaceutical compositions for preventing or treating th1-mediated immune diseases
12/23/2004	CA2528382A1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them
12/23/2004	CA2528367A1 A1 adenosine receptor antagonists
12/23/2004	CA2527608A1 Pharmaceutically useful salts of carboxylic acid derivates
12/23/2004	CA2527246A1 Aniline derivatives
12/23/2004	CA2527033A1 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	CA2526518A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
12/23/2004	CA2526204A1 Pyridinyl carbamates as hormone-sensitive lipase inhibitors
12/23/2004	CA2526169A1 Fusion proteins
12/23/2004	CA2525207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
12/22/2004	EP1489172A1 Nuclear receptor err gamma 3
12/22/2004	EP1489171A1 Functional molecule and process for producing the same
12/22/2004	EP1489096A1 Novel hemepeptide
12/22/2004	EP1489089A1 Crystals of glucopyranosyloxybenzyl benzene derivative
12/22/2004	EP1489088A1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative
12/22/2004	EP1489077A1 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
12/22/2004	EP1488811A1 Tablets quickly disintegrating in oral cavity
12/22/2004	EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
12/22/2004	EP1488793A1 PREVENTIVES OR REMEDIES FOR DISEAES CAUSED BY eNOS EXPRESSION
12/22/2004	EP1487967A2 Chimeric pancreas
12/22/2004	EP1487874A1 Falp proteins
12/22/2004	EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/22/2004	EP1487843A2 Substituted phenylacetic acids
12/22/2004	EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/22/2004	EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt

1 ... 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 ... 1298